Gilead’s Kite to buy ex-Agensys R&D site for $135M: report by Nick Paul Taylor Monday, January 22, 2018 The big biotech has bid $135 million for a 160,000-square-foot site in California formerly occupied by Astellas’ Agensys.
Astellas winds down Agensys antibody unit by Phil Taylor Thursday, July 27, 2017 Ten years after taking over Agensys in a $537 million deal, Japan's Astellas has decided to pull the plug on the Santa Monica-based operation.
